Lupin launches Corcal Bone and Beauty supplement Lakshmipriya Nair May 10, 2018 Corcal Bone and Beauty is available in packs of 10 mini-tablets
Epygen plans to raise Rs 300 cr to propel biosimilars in India Lakshmipriya Nair May 10, 2018 The funds will be utlilised for clinical trials of pipeline molecules and securing IP for technologies for novel biological…
Glenmark Pharma to present updated info on GBR 830 at International Investigative Dermatology… Lakshmipriya Nair May 10, 2018 GBR 830 is a first-in-class, investigational, anti-OX40 monoclonal antibody for treatment of moderate-to-severe atopic dermatitis
Annual Opex in Pharma Summit to be held in Mumbai Lakshmipriya Nair May 10, 2018 The event will discuss on how pharma manufacturers should efficiently implement excellence initiatives
Cipla partners with MannKind for Afrezza – inhaled insulin Lakshmipriya Nair May 10, 2018 Signs deal for exclusive marketing and distribution of the only US FDA approved inhaled insulin
Unichem Laboatories’ Valsartan tablets receives ANDA approval Swati Rana May 9, 2018 To treat hypertension, heart failure (NYHA class II – IV) and reduces cardiovascular mortality in clinically stable patients
AstraZeneca & Merck’s Lynparza tablets receive EU approval Swati Rana May 9, 2018 For the treatment of platinum-sensitive relapsed ovarian cancer
Strides & Apotex agree to merge their Australian businesses Swati Rana May 9, 2018 Hospital business of Apotex will not form part of the merged entity and will be retained by Apotex
Suven Life Sciences secures product patents in Australia, Eurasia and Europe Swati Rana May 9, 2018 Products are being developed for cognitive disorders with high unmet medical need and with huge market potential globally
Lupin submits NDA for Etanercept biosimilar in Japan Swati Rana May 9, 2018 Etanercept (YLB113) is indicated for moderate to severe Rheumatoid Arthritis (RA) and Juvenile Idiopathic Arthritis